Articles tagged with: CP-4200
AA&MDSIF Living with MDS: One day conference – On May 16, the Aplastic Anemia and MDS International Foundation (AA&MDSIF) in collaboration with the Cleveland Clinic Taussig Cancer Institute, will hold a free one day conference in Cleveland for myelodysplastic syndromes (MDS) patients and their families. Leading experts will discuss the latest in diagnosis, treatment, and maximizing physical and mental health throughout treatment. For more information, see the AA&MDSIF Web site.
Preclinical Data Released For Drug Candidate CP-4200 – Clavis Pharma announced positive preclinical data for CP-4200 in the treatment of …